Swift, Erica
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Mr. Cedrone, 
`
`Swift, Erica
`Friday, February 4, 2022 10:24 AM
`Cedrone, Gerard J
`Delsignore, Marta E; Wiesen, Daryl L; Rapalino, Emily L.; Irving, Tom; Feldstein, Mark; Ward, Trenton
`(External); Corser, C. Collette; FinneganIncyte-PGR2020; PTAB Hearings; Cannon, Kulunie
`RE: PGR2021-00006 (Incyte Corp. v. Concert Pharmaceuticals, Inc.) -- LEAP Request and Verification
`
`Thank you for following up.  I apologize for the delay in responding. 
`
`Patent Owner’s request to participate in the oral hearing as a LEAP practitioner is granted. Patent Owner is granted an 
`additional fifteen minutes of argument time during the oral hearing. For guidance regarding LEAP, please visit the USPTO 
`website: www.uspto.gov/leap. 
`
`Best,
`
`PTAB Hearings
`
`From: Cedrone, Gerard J <GCedrone@goodwinlaw.com>  
`Sent: Thursday, January 27, 2022 6:05 PM 
`To: PTAB Hearings <PTABHearings@USPTO.GOV> 
`Cc: Delsignore, Marta E <MDelsignore@goodwinlaw.com>; Wiesen, Daryl L <DWiesen@goodwinlaw.com>; Rapalino, 
`Emily L. <ERapalino@goodwinlaw.com>; Irving, Tom <tom.irving@finnegan.com>; Feldstein, Mark 
`<mark.feldstein@finnegan.com>; Ward, Trenton (External) <trenton.ward@finnegan.com>; Corser, C. Collette 
`<collette.corser@finnegan.com>; FinneganIncyte‐PGR2020 <FinneganIncyte‐PGR2020@finnegan.com> 
`Subject: PGR2021‐00006 (Incyte Corp. v. Concert Pharmaceuticals, Inc.) ‐‐ LEAP Request and Verification 
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before responding, clicking on 
`links, or opening attachments. 
`
`To the Honorable Board: 
`
`Attached please find a completed LEAP request and verification on behalf of Patent Owner Concert Pharmaceuticals, 
`Inc., in the above matter, which is scheduled for oral argument on February 10, 2022. 
`
`Please let me know if you require any additional information.  Thank you for your consideration. 
`
`1
`
`

`

`  
`
`Regards, 
`
`  
`Gerard J. Cedrone 
`
`
`
`
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210 
`o +1 617 570 1849
`f +1 617 801 8645
`GCedrone@goodwinlaw.com
`
`
`
`
`
`
`
`
`
`
`
` 
`
`  
`
`
`*******************************************************************
`This message was sent from Goodwin Procter LLP and is intended only for the designated recipient(s). It may
`contain confidential or proprietary information and may be subject to the attorney-client privilege or other
`confidentiality protections. If you are not a designated recipient, you may not review, copy or distribute this
`message. If you receive this in error, please notify the sender by reply e-mail and delete this message. Thank
`you.
`*******************************************************************
`
`2
`
`

`

`(cid:87)(cid:100)(cid:75)(cid:876)(cid:94)(cid:17)(cid:876)(cid:1008)(cid:1009)(cid:1009)(cid:3)(cid:894)(cid:1005)(cid:1005)(cid:882)(cid:1006)(cid:1005)(cid:895)
`United States Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`LEAP PRACTITIONER VERIFICATION FORM AND REQUEST FOR ORAL
`HEARING PARTICIPATION
`Concert Pharmaceuticals, Inc.
`On behalf of
`Patent Owner
`Gerard J. Cedrone
`(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:86)(cid:87)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:82)(cid:85)(cid:68)(cid:79)(cid:3)(cid:75)(cid:72)(cid:68)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)
`(cid:3)(cid:82)(cid:81)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:86)(cid:70)(cid:75)(cid:72)(cid:71)(cid:88)(cid:79)(cid:72)(cid:71)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:81)(cid:82)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:72)(cid:79)(cid:82)(cid:90)(cid:17)
`PGR2021-00006
`Pursuant to 28 U.S.C. § 1746, I, , certify that I
`Gerard J. Cedrone
`am eligible to participate in the Legal Experience and Advancement Program (LEAP)
`program. I have three or fewer substantive oral hearing arguments before federal
`tribunals, including PTAB.
`I certify/verify under penalty of perjury under the laws of the United States of
`America that the foregoing is true and correct.
`
`(cid:15)
`
`Hearing Information
`Requesting Party:
`Concert Pharmaceuticals, Inc.
`Appeal/Case/Control Number:
`PGR2021-00006
`Hearing Date (mm/dd/yyyy):
`02/10/2022
`LEAP Practitioner Contact Information
`LEAP Practitioner Name:
`Gerard J. Cedrone
`Firm Name:
`Goodwin Procter LLP
`Street Address 1:
`100 Northern Avenue
`Street Address 2:
`City:
`Boston
`State/Province:
`Country:
`Email:
`
`gcedrone@goodwinlaw.com
`
`Date:
`
`01/27/2022
`
`/s/ Gerard J. Cedrone
`(Signature)
`
`MA
`
`USA
`
`Zip/Postal Code:
`02210
`Phone Number:
`
`617-570-1849
`
`

`

`(cid:87)(cid:100)(cid:75)(cid:876)(cid:94)(cid:17)(cid:876)(cid:1008)(cid:1009)(cid:1009)(cid:3)(cid:894)(cid:1004)(cid:1009)(cid:882)(cid:1006)(cid:1005)(cid:895)
`United States Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Privacy Act Statement
`The United States Patent and Trademark Offic (USPTO) collects this information under authority of 35
`U.S.C. 2(b)(2). The information you provide will be used to register to participate in Agency-sponsored
`events and programs designed to disseminate information to the public on topics related to patents and
`trademarks. This system includes information about individuals who have requested participation in an
`Agency-sponsored event or program. The information is protected from disclosure to third parties in
`accordance with the Privacy Act. However, routine uses of this information may include disclosure to
`the following: to non-Federal personnel under contract to the Agency; to a court for adjudication and
`litigation; to the Department of Justice for Freedom of Information Act (FOIA) assistance; to members
`of Congress; and to National Archives and Records Administration. If you do not furnish the requested
`information, the USPTO may not be able to process your request for participation in the event or
`program. The applicable Privacy Act System of Records Notice for this information request is PAT-TM-
`19, Dissemination Events and Registrations: Federal Register vol. 71 December 27, 2006, page 77739,
`available at https://www.federalregister.gov/documents/2006/12/27/E6-22122/privacy-act-of-1974-
`system-of-records
`
`